LONDON (AP) - The first affordable combination anti-malarial drug tailored for children will soon be available across Africa, potentially saving millions of lives, the nonprofit organization and the pharmaceuticals giant who worked to develop it said Thursday.
FULL STORY

Source: Canadian Online Health News